UCB SA (VIE:UCB)
Austria flag Austria · Delayed Price · Currency is EUR
183.45
-7.80 (-4.08%)
At close: Aug 1, 2025, 5:30 PM CET

SpringWorks Therapeutics Revenue

UCB SA had revenue of 3.36B EUR in the half year ending December 31, 2024. This brings the company's revenue in the last twelve months to 6.85B, up 25.56% year-over-year. In the year 2024, UCB SA had annual revenue of 6.15B with 18.72% growth.

Revenue (ttm)
6.85B
Revenue Growth
+25.56%
P/S Ratio
5.13
Revenue / Employee
743.14K
Employees
9,378
Market Cap
35.13B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20246.15B970.00M18.72%
Dec 31, 20235.18B-265.00M-4.87%
Dec 31, 20225.45B-330.00M-5.71%
Dec 31, 20215.78B430.00M8.04%
Dec 31, 20205.35B434.00M8.83%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition